|
Volumn 115, Issue 2, 2001, Pages 253-256
|
Primary breast lymphoma: A report of 20 cases
a a a a a a a a |
Author keywords
Chemotherapy; Primary breast lymphoma; Prognostic factors; Relapse
|
Indexed keywords
BLEOMYCIN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DOXORUBICIN;
METHOTREXATE;
PREDNISOLONE;
VINCRISTINE;
ADULT;
AGED;
ARTICLE;
B CELL LYMPHOMA;
B LYMPHOCYTE;
BIOAVAILABILITY;
BREAST CARCINOMA;
BURKITT LYMPHOMA;
CENTRAL NERVOUS SYSTEM;
CHEMOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE ASSOCIATION;
FEMALE;
FOLLOW UP;
HUMAN;
MALE;
PRIORITY JOURNAL;
PROPHYLAXIS;
RELAPSE;
REMISSION;
RETROSPECTIVE STUDY;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CYCLOPHOSPHAMIDE;
DISEASE-FREE SURVIVAL;
DOXORUBICIN;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
LYMPHOMA, B-CELL;
MIDDLE AGED;
PREDNISONE;
PROGNOSIS;
RECURRENCE;
RETROSPECTIVE STUDIES;
SURVIVAL RATE;
TENIPOSIDE;
TREATMENT OUTCOME;
VINCRISTINE;
|
EID: 0035723710
PISSN: 00071048
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2141.2001.03047.x Document Type: Article |
Times cited : (90)
|
References (17)
|